Johns Hopkins Transplant Research Center (TRC) and the New York University Center for Surgical and Applied Transplant Research have conducted a research study among 2,400 solid organ transplant recipients. The study indicated an increase in post-vaccination SARS-CoV-2 viral infections. Yet surprisingly, the hospitalization rates have shown a significant decline in following the first wave of the virus’ omicron subvariant.
JAMA Network Open published a research study on August 18, 2023. The study is considered “a bit of a capstone,” according to the researchers. The research study among organ transplant recipients showed some significant results. Around 464 of 2,356 participants or 19.7% of the research population show SARS-CoV-2 infections. However, out of that, only 35 (or 7.5%) required hospitalization.
“However, we did find that certain groups -; primarily patients who had received lung transplants -; remained at higher risk for hospitalization during more contemporary subvariant eras,” says William Werbel, the senior study author, assistant professor of medicine, and associate director of the TRC’s epidemiology and quantitative sciences at the Johns Hopkins University School of Medicine.
The study author also says that this research provides an evidence-based framework to educate the benefits of vaccination. Specially among people who are most vulnerable to COVID, such as transplant patients. The study is a hope for many patients who went through an organ transplant.
Journal Reference:
Chiang, T, P. (2023). Incident COVID-19 and Hospitalizations by Variant Era Among Vaccinated Solid Organ Transplant Recipients. JAMA Network Open. doi.org/10.1001/jamanetworkopen.2023.29736.
Also read,
- A Scientific Breakthrough In Treating Alcohol Addiction!
- Canadians are Now Safe From Covid | Researchers proved Canadians have Hybrid Immunity to Covid
